Bayesian Capital Management’s New York Times NYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,406
Closed -$1.14M 988
2024
Q1
$1.14M Buy
+26,406
New +$1.2M 0.11% 261
2023
Q4
Sell
-15,006
Closed -$618K 953
2023
Q3
$618K Buy
+15,006
New +$631K 0.07% 328
2022
Q3
Sell
-13,800
Closed -$385K 928
2022
Q2
$385K Sell
13,800
-29,100
-68% -$1.05M 0.07% 400
2022
Q1
$1.97M Buy
+42,900
New +$1.86M 0.29% 73
2020
Q3
Sell
-27,432
Closed -$1.15M 641
2020
Q2
$1.15M Buy
27,432
+5,000
+22% +$182K 0.25% 106
2020
Q1
$689K Buy
+22,432
New +$771K 0.15% 207
2019
Q3
Sell
-17,100
Closed -$558K 636
2019
Q2
$558K Buy
17,100
+3,400
+25% +$113K 0.12% 241
2019
Q1
$450K Buy
+13,700
New +$406K 0.09% 312
2018
Q2
Sell
-21,300
Closed -$513K 677
2018
Q1
$513K Buy
+21,300
New +$489K 0.13% 263
2016
Q1
Sell
-21,400
Closed -$287K 415
2015
Q4
$287K Buy
+21,400
New +$286K 0.41% 108

Other funds holding NYT

Bayesian Capital Management's NYT Position: Q2 2024 in Review

Bayesian Capital Management sold out of New York Times (NYT) in Q2 2024, closing a stake of 26,406 shares — an estimated $1.14M sold.

Bayesian Capital Management first reported a position in NYT in Q4 2015 and held it in 10 quarters. The position peaked at $1.97M in Q1 2022. 440 funds tracked by Wall St. Rank hold NYT as of Q2 2024.

  • Bayesian Capital Management reported no remaining New York Times position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 26,406 New York Times shares in Q2 2024, an estimated $1.14M.
  • Bayesian Capital Management first reported a position in New York Times in Q4 2015 and held it in 10 quarters.
  • Bayesian Capital Management's New York Times position peaked at $1.97M in Q1 2022.
  • 440 funds tracked by Wall St. Rank held New York Times as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.